CommercialPrior AuthMedium impact
Effective Sept. 1, 2024, Medical Mutual is Enacting a Medications Subject to Dose Optimization Policy
Medical Mutual of Ohio·Allergy & Immunology, Hematology, Oncology +2 more·In the News
Effective date
Sep 1, 2024
We identified it
Jun 20, 2026
Summary
Effective September 1, 2024, Medical Mutual is implementing a new Medications Subject to Dose Optimization policy for immune globulin medications. This policy creates shorter prior authorization periods for providers who do not participate in their voluntary dose optimization program, while all affected medications still require prior authorization.
Action Required
By September 1, 2024: Billing team must update prior authorization tracking for all immune globulin medications (J-codes listed) to monitor shortened authorization periods for providers not participating in Medical Mutual's dose optimization program. Notify providers about the voluntary dose optimization program to avoid limited authorization periods. Verify prior authorization status more frequently for these medications as authorization periods may be shorter than standard Corporate Medical Policy timeframes.